Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
نویسندگان
چکیده
Piperacillin-tazobactam is one of the most common causes of drug-induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF). Here, we report a case of life-threatening piperacillin-tazobactam-associated DIIHA in a 30-year-old woman with CF and propose management recommendations for piperacillin-tazobactam-associated DIIHA in CF patients.
منابع مشابه
Piperacillin-Induced Immune Hemolytic Anemia in an Adult with Cystic Fibrosis
We report a case of drug-induced immune hemolytic anemia (DIIHA) in an adult female with cystic fibrosis (CF), complicating routine treatment of a pulmonary exacerbation with intravenous piperacillin-tazobactam. Workup revealed a positive direct antiglobulin test (DAT) due to red blood cell (RBC)-bound IgG and C3 and piperacillin antibodies detectable in the patient's serum. The potential influ...
متن کاملSudden onset of severe anemia in a patient with cystic fibrosis.
A 26-year-old woman with end-stage lung disease secondary to cystic fibrosis, cirrhosis secondary to hepatitis C, and insulin-dependent diabetes mellitus presented with acute pneumonia. She was treated with intravenous piperacillin/tazobactam and tobramycin. Other medications included dexamethasone, bumetanide, pantoprazole, dornase, and insulin. At admission, the patient’s hematocrit was 30.8%...
متن کاملPiperacillin-Induced Immune Hemolysis Presenting with Tachycardia and Cardiac Arrest
A 20-year-old nonverbal patient with profound developmental disabilities was treated with intravenous piperacillin-tazobactam for respiratory infection. After 8 days, he became afebrile with normal pulmonary status, but his pulse remained inexplicably rapid (114/minute). Investigations revealed severe normochromic normocytic hemolytic anemia (hemoglobin: 40 g/L, reticulocytes: 9.4%, nucleated e...
متن کاملEmerging cystic fibrosis pathogens: incidence and antimicrobial resistance.
We examined the frequency of isolation and the antimicrobial resistance of Burkholderia cepacia complex, Stenotrophomonas maltophilia and Achromobacter xylosoxidans in cystic fibrosis patients from 2000 to 2004. Strains susceptibility to tobramycin, piperacillin/tazobactam, imipenem, gentamicin, ciprofloxacin and ceftazidime was determined by disc diffusion assay. B. cepacia complex showed a ve...
متن کاملAntimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis.
Stenotrophomonas maltophilia is a newly emerging pathogen being detected with increasing frequency in patients with cystic fibrosis (CF). The impact of this multidrug-resistant organism on lung function is uncertain. The optimal treatment for S. maltophilia in CF patients is unknown. We studied the in vitro activity of ten antimicrobial agents, and conducted synergy studies by using checkerboar...
متن کامل